Global Recombinant Human Insulin Sales Market Report 2017

February 2017 | 123 pages | ID: GFFDB897894EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Recombinant Human Insulin

Revenue, means the sales value of Recombinant Human Insulin

This report studies sales (consumption) of Recombinant Human Insulin in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novo Nordisk
• Eli Lilly
• Bioton
• Dongbao
• United Laboratories (TUL)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Recombinant Human Insulin in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Human Insulin in each application, can be divided into

• Application 1
• Application 2

Contents

Global Recombinant Human Insulin Sales Market Report 2017

1 RECOMBINANT HUMAN INSULIN OVERVIEW

1.1 Product Overview and Scope of Recombinant Human Insulin
1.2 Classification of Recombinant Human Insulin
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Recombinant Human Insulin
  1.3.1 Application
  1.3.2 Application
1.4 Recombinant Human Insulin Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Recombinant Human Insulin (2012-2022)
  1.5.1 Global Recombinant Human Insulin Sales and Growth Rate (2012-2022)
  1.5.2 Global Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

2 GLOBAL RECOMBINANT HUMAN INSULIN COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Recombinant Human Insulin Market Competition by Manufacturers
  2.1.1 Global Recombinant Human Insulin Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Recombinant Human Insulin Revenue and Share by Manufacturers (2012-2017)
2.2 Global Recombinant Human Insulin (Volume and Value) by Type
  2.2.1 Global Recombinant Human Insulin Sales and Market Share by Type (2012-2017)
  2.2.2 Global Recombinant Human Insulin Revenue and Market Share by Type (2012-2017)
2.3 Global Recombinant Human Insulin (Volume and Value) by Regions
  2.3.1 Global Recombinant Human Insulin Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Recombinant Human Insulin Revenue and Market Share by Regions (2012-2017)
2.4 Global Recombinant Human Insulin (Volume) by Application

3 UNITED STATES RECOMBINANT HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

3.1 United States Recombinant Human Insulin Sales and Value (2012-2017)
  3.1.1 United States Recombinant Human Insulin Sales and Growth Rate (2012-2017)
  3.1.2 United States Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
  3.1.3 United States Recombinant Human Insulin Sales Price Trend (2012-2017)
3.2 United States Recombinant Human Insulin Sales and Market Share by Manufacturers
3.3 United States Recombinant Human Insulin Sales and Market Share by Type
3.4 United States Recombinant Human Insulin Sales and Market Share by Application

4 CHINA RECOMBINANT HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

4.1 China Recombinant Human Insulin Sales and Value (2012-2017)
  4.1.1 China Recombinant Human Insulin Sales and Growth Rate (2012-2017)
  4.1.2 China Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
  4.1.3 China Recombinant Human Insulin Sales Price Trend (2012-2017)
4.2 China Recombinant Human Insulin Sales and Market Share by Manufacturers
4.3 China Recombinant Human Insulin Sales and Market Share by Type
4.4 China Recombinant Human Insulin Sales and Market Share by Application

5 EUROPE RECOMBINANT HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Recombinant Human Insulin Sales and Value (2012-2017)
  5.1.1 Europe Recombinant Human Insulin Sales and Growth Rate (2012-2017)
  5.1.2 Europe Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Recombinant Human Insulin Sales Price Trend (2012-2017)
5.2 Europe Recombinant Human Insulin Sales and Market Share by Manufacturers
5.3 Europe Recombinant Human Insulin Sales and Market Share by Type
5.4 Europe Recombinant Human Insulin Sales and Market Share by Application

6 JAPAN RECOMBINANT HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Recombinant Human Insulin Sales and Value (2012-2017)
  6.1.1 Japan Recombinant Human Insulin Sales and Growth Rate (2012-2017)
  6.1.2 Japan Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Recombinant Human Insulin Sales Price Trend (2012-2017)
6.2 Japan Recombinant Human Insulin Sales and Market Share by Manufacturers
6.3 Japan Recombinant Human Insulin Sales and Market Share by Type
6.4 Japan Recombinant Human Insulin Sales and Market Share by Application

7 SOUTHEAST ASIA RECOMBINANT HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Recombinant Human Insulin Sales and Value (2012-2017)
  7.1.1 Southeast Asia Recombinant Human Insulin Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Recombinant Human Insulin Sales Price Trend (2012-2017)
7.2 Southeast Asia Recombinant Human Insulin Sales and Market Share by Manufacturers
7.3 Southeast Asia Recombinant Human Insulin Sales and Market Share by Type
7.4 Southeast Asia Recombinant Human Insulin Sales and Market Share by Application

8 INDIA RECOMBINANT HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

8.1 India Recombinant Human Insulin Sales and Value (2012-2017)
  8.1.1 India Recombinant Human Insulin Sales and Growth Rate (2012-2017)
  8.1.2 India Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
  8.1.3 India Recombinant Human Insulin Sales Price Trend (2012-2017)
8.2 India Recombinant Human Insulin Sales and Market Share by Manufacturers
8.3 India Recombinant Human Insulin Sales and Market Share by Type
8.4 India Recombinant Human Insulin Sales and Market Share by Application

9 GLOBAL RECOMBINANT HUMAN INSULIN MANUFACTURERS ANALYSIS

9.1 Novo Nordisk
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Recombinant Human Insulin Product Type, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Novo Nordisk Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Eli Lilly
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Recombinant Human Insulin Product Type, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Eli Lilly Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Bioton
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Recombinant Human Insulin Product Type, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bioton Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Dongbao
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Recombinant Human Insulin Product Type, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Dongbao Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 United Laboratories (TUL)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Recombinant Human Insulin Product Type, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 United Laboratories (TUL) Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview

10 RECOMBINANT HUMAN INSULIN MAUFACTURING COST ANALYSIS

10.1 Recombinant Human Insulin Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Recombinant Human Insulin
10.3 Manufacturing Process Analysis of Recombinant Human Insulin

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Recombinant Human Insulin Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Recombinant Human Insulin Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL RECOMBINANT HUMAN INSULIN MARKET FORECAST (2017-2022)

14.1 Global Recombinant Human Insulin Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Recombinant Human Insulin Price and Trend Forecast (2017-2022)
14.2 Global Recombinant Human Insulin Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Recombinant Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Recombinant Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Recombinant Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Recombinant Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Recombinant Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Recombinant Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Recombinant Human Insulin Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Recombinant Human Insulin Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Human Insulin
Table Classification of Recombinant Human Insulin
Figure Global Sales Market Share of Recombinant Human Insulin by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Recombinant Human Insulin
Figure Global Sales Market Share of Recombinant Human Insulin by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure China Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Europe Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Japan Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure India Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Global Recombinant Human Insulin Sales and Growth Rate (2012-2022)
Figure Global Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Table Global Recombinant Human Insulin Sales of Key Manufacturers (2012-2017)
Table Global Recombinant Human Insulin Sales Share by Manufacturers (2012-2017)
Figure 2015 Recombinant Human Insulin Sales Share by Manufacturers
Figure 2016 Recombinant Human Insulin Sales Share by Manufacturers
Table Global Recombinant Human Insulin Revenue by Manufacturers (2012-2017)
Table Global Recombinant Human Insulin Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Recombinant Human Insulin Revenue Share by Manufacturers
Table 2016 Global Recombinant Human Insulin Revenue Share by Manufacturers
Table Global Recombinant Human Insulin Sales and Market Share by Type (2012-2017)
Table Global Recombinant Human Insulin Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Human Insulin by Type (2012-2017)
Figure Global Recombinant Human Insulin Sales Growth Rate by Type (2012-2017)
Table Global Recombinant Human Insulin Revenue and Market Share by Type (2012-2017)
Table Global Recombinant Human Insulin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Insulin by Type (2012-2017)
Figure Global Recombinant Human Insulin Revenue Growth Rate by Type (2012-2017)
Table Global Recombinant Human Insulin Sales and Market Share by Regions (2012-2017)
Table Global Recombinant Human Insulin Sales Share by Regions (2012-2017)
Figure Sales Market Share of Recombinant Human Insulin by Regions (2012-2017)
Figure Global Recombinant Human Insulin Sales Growth Rate by Regions (2012-2017)
Table Global Recombinant Human Insulin Revenue and Market Share by Regions (2012-2017)
Table Global Recombinant Human Insulin Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Recombinant Human Insulin by Regions (2012-2017)
Figure Global Recombinant Human Insulin Revenue Growth Rate by Regions (2012-2017)
Table Global Recombinant Human Insulin Sales and Market Share by Application (2012-2017)
Table Global Recombinant Human Insulin Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Human Insulin by Application (2012-2017)
Figure Global Recombinant Human Insulin Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure United States Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure United States Recombinant Human Insulin Sales Price Trend (2012-2017)
Table United States Recombinant Human Insulin Sales by Manufacturers (2012-2017)
Table United States Recombinant Human Insulin Market Share by Manufacturers (2012-2017)
Table United States Recombinant Human Insulin Sales by Type (2012-2017)
Table United States Recombinant Human Insulin Market Share by Type (2012-2017)
Table United States Recombinant Human Insulin Sales by Application (2012-2017)
Table United States Recombinant Human Insulin Market Share by Application (2012-2017)
Figure China Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure China Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure China Recombinant Human Insulin Sales Price Trend (2012-2017)
Table China Recombinant Human Insulin Sales by Manufacturers (2012-2017)
Table China Recombinant Human Insulin Market Share by Manufacturers (2012-2017)
Table China Recombinant Human Insulin Sales by Type (2012-2017)
Table China Recombinant Human Insulin Market Share by Type (2012-2017)
Table China Recombinant Human Insulin Sales by Application (2012-2017)
Table China Recombinant Human Insulin Market Share by Application (2012-2017)
Figure Europe Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure Europe Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure Europe Recombinant Human Insulin Sales Price Trend (2012-2017)
Table Europe Recombinant Human Insulin Sales by Manufacturers (2012-2017)
Table Europe Recombinant Human Insulin Market Share by Manufacturers (2012-2017)
Table Europe Recombinant Human Insulin Sales by Type (2012-2017)
Table Europe Recombinant Human Insulin Market Share by Type (2012-2017)
Table Europe Recombinant Human Insulin Sales by Application (2012-2017)
Table Europe Recombinant Human Insulin Market Share by Application (2012-2017)
Figure Japan Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure Japan Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure Japan Recombinant Human Insulin Sales Price Trend (2012-2017)
Table Japan Recombinant Human Insulin Sales by Manufacturers (2012-2017)
Table Japan Recombinant Human Insulin Market Share by Manufacturers (2012-2017)
Table Japan Recombinant Human Insulin Sales by Type (2012-2017)
Table Japan Recombinant Human Insulin Market Share by Type (2012-2017)
Table Japan Recombinant Human Insulin Sales by Application (2012-2017)
Table Japan Recombinant Human Insulin Market Share by Application (2012-2017)
Figure Southeast Asia Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure Southeast Asia Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Recombinant Human Insulin Sales Price Trend (2012-2017)
Table Southeast Asia Recombinant Human Insulin Sales by Manufacturers (2012-2017)
Table Southeast Asia Recombinant Human Insulin Market Share by Manufacturers (2012-2017)
Table Southeast Asia Recombinant Human Insulin Sales by Type (2012-2017)
Table Southeast Asia Recombinant Human Insulin Market Share by Type (2012-2017)
Table Southeast Asia Recombinant Human Insulin Sales by Application (2012-2017)
Table Southeast Asia Recombinant Human Insulin Market Share by Application (2012-2017)
Figure India Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure India Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure India Recombinant Human Insulin Sales Price Trend (2012-2017)
Table India Recombinant Human Insulin Sales by Manufacturers (2012-2017)
Table India Recombinant Human Insulin Market Share by Manufacturers (2012-2017)
Table India Recombinant Human Insulin Sales by Type (2012-2017)
Table India Recombinant Human Insulin Market Share by Type (2012-2017)
Table India Recombinant Human Insulin Sales by Application (2012-2017)
Table India Recombinant Human Insulin Market Share by Application (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Recombinant Human Insulin Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Recombinant Human Insulin Global Market Share (2012-2017)
Table Bioton Basic Information List
Table Bioton Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bioton Recombinant Human Insulin Global Market Share (2012-2017)
Table Dongbao Basic Information List
Table Dongbao Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dongbao Recombinant Human Insulin Global Market Share (2012-2017)
Table United Laboratories (TUL) Basic Information List
Table United Laboratories (TUL) Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure United Laboratories (TUL) Recombinant Human Insulin Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Insulin
Figure Manufacturing Process Analysis of Recombinant Human Insulin
Figure Recombinant Human Insulin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Insulin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Insulin
Table Distributors/Traders List
Figure Global Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
Figure Global Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Table Global Recombinant Human Insulin Sales Forecast by Regions (2017-2022)
Table Global Recombinant Human Insulin Sales Forecast by Type (2017-2022)
Table Global Recombinant Human Insulin Sales Forecast by Application (2017-2022)